GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription SalesBenzinga • 02/27/25
Insights Into GoodRx (GDRX) Q4: Wall Street Projections for Key MetricsZacks Investment Research • 02/25/25
GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity ThreatsBusiness Wire • 02/18/25
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference CallBusiness Wire • 01/30/25
GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by WildfiresBusiness Wire • 01/10/25
GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet MedicationsBusiness Wire • 01/07/25
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdownCNBC • 12/24/24
GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. CountiesBusiness Wire • 12/17/24
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive OfficerBusiness Wire • 12/16/24
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx saysCNBC • 12/05/24
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still SurgedBusiness Wire • 12/05/24
GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity ScholarshipBusiness Wire • 11/18/24
Harrow Launches Access and Affordability Program with Price Reductions for Branded ProductsBusiness Wire • 11/13/24
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 11/13/24
GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/07/24